Sort
35,931 grants matching “parkinsons”
Characterization of Dementia with Lewy Bodies: A Collaborative Study
$531,192Thomas J Montine · University Of Washington · R01 · FY2007 · NS
NEUROVASCULAR CHANGES ASSOCIATED WITH OLFACTORY DEFICITS IN EARLY PARKINSON'S DISEASE
$531,188Hugo W. Moser Research Institute At Kennedy Krieger, Inc. · · FY2017 · Department of the Army
Quantitative mapping of substantia nigra iron in Parkinson's Disease
$531,099Yi Wang · Weill Medical Coll Of Cornell Univ · R01 · FY2021 · NS
Muscarinic acetylcholine receptor subtypes: physiological roles
$530,931Jurgen Wess · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2013 · DK
Mechanisms of Novel Regulators of Proteotoxicity and Quality Control Associated with ALS/FTD
$530,927Jiou Wang · Johns Hopkins University · R01 · FY2023 · NS
Mechanisms of Novel Regulators of Proteotoxicity and Quality Control Associated with ALS/FTD
$530,927Jiou Wang · Johns Hopkins University · R01 · FY2024 · NS
Metabolic Interventions for Sleep, Anesthesia-related Neurocognitive Disorders and Alzheimer's Disease
$530,816Christa Joy Nehs · Massachusetts General Hospital · R01 · FY2023 · AG
Metabolic Interventions for Sleep, Anesthesia-related Neurocognitive Disorders and Alzheimer's Disease
$530,816Christa Joy Nehs · Massachusetts General Hospital · R01 · FY2024 · AG
High-Speed, Depth-Resolved Images of Cardiac physiology
$530,808University Of Pittsburgh At Pittsburgh · R01 · FY2003 · HL
Neuroscience of Aging, Neurodegeneration and Alzheimer's Disease
$530,665Jacob Raber · Oregon Health & Science University · T32 · FY2024 · AG
Hypothalamic-Pituitary-Adrenal Axis and Alcoholism
$530,655Gary S Wand · Johns Hopkins University · R01 · FY2011 · AA
Impact of Anticholinergic and Dopamine Receptor Blocking Drug Exposure on Parkinson Disease Trajectory and Outcomes
$530,531Allison Willis · University Of Pennsylvania · R01 · FY2019 · NS
Impact of Anticholinergic and Dopamine Receptor Blocking Drug Exposure on Parkinson Disease Trajectory and Outcomes
$530,531Allison Willis · University Of Pennsylvania · R01 · FY2021 · NS
Impact of Anticholinergic and Dopamine Receptor Blocking Drug Exposure on Parkinson Disease Trajectory and Outcomes
$530,531Allison Willis · University Of Pennsylvania · R01 · FY2020 · NS
Neurophysiology of movement transitions in Parkinson's disease with freezing of gait
$530,442Sommer L Huffmaster · University Of Minnesota · R01 · FY2025 · NS
Clinical- Neuropathology Coreitm
$530,221Susan Spear Bassett · Johns Hopkins University · P50 · FY2012 · NS
PET imaging of soluble epoxide hydrolase (sEH) in human subjects
$530,176Andrew G Horti · Johns Hopkins University · R33 · FY2020 · AG
Gender Effects on Amphetamine-Induced Dopamine Release and Subjective Responses
$530,118Mary E McCaul · Johns Hopkins University · R01 · FY2010 · DA
Patient Specific Parameter Optimization of Thalamic Stimulation for Treatment of Epilepsy
$530,004Robert A McGovern · University Of Minnesota · U01 · FY2022 · NS
Striatal Dopamine Signals Underlying Valence-Dependent Learning
$529,997Helen N Schwerdt · University Of Pittsburgh At Pittsburgh · R01 · FY2025 · NS
Neuronal Activity in MC and SMA during STN and GPi DBS in the Parkinsonian Monkey
$529,826Jerrold L Vitek · University Of Minnesota · R01 · FY2012 · NS
Health Effects Of Exposures In Agriculture
$529,644Dale P Sandler · National Institute Of Environmental Health Sciences · ZIA · FY2023 · ES
High-Throughput Genomic Approaches to Identify ALS Genes
$529,594Massachusetts General Hospital · R01 · FY2005 · NS
Mechanisms of persistent neural activity
$529,477Alexander C Huk · University Of California Los Angeles · R01 · FY2023 · EY
Genomic Screen To Identify Alzheimers Disease Genes
$529,367Duke University · R01 · FY2005 · NS